Memphis Pharmaceuticals & Chemical Industries (EGX: MPCI)

MPCI Revenue

In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M EGP with 31.34% growth. Memphis Pharmaceuticals & Chemical Industries had revenue of 207.33M in the quarter ending June 30, 2024, a decrease of -7.18%.

• Revenue: 871.91M
• Revenue Growth: +31.34%
• P/S Ratio: 0.39
• Revenue / Employee: 6.05M
• Employees: 144
• Market Cap: 339.19M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%
Jun 30, 2021	518.11M	29.70M	6.08%
Jun 30, 2020	488.41M	125.34M	34.52%